Hanel ML , Hensey C .

057990/2/99/2 Wellcome Trust , 061410/GM/SP/JAT Wellcome Trust

             optic vesicle morphogenesis
             BMP signaling pathway
             positive regulation of apoptotic process

                coloboma

           MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6

Xla Wt + gdf6 (Fig.1.E)
Xla Wt + gdf6 MO (Fig.1.I,J)
Xla Wt + gdf6 MO (Fig.2.B,D,F,H)
Xla Wt + gdf6 MO (Fig.3.B,C,E,F)
Xla Wt + gdf6 MO (Fig.4.A,C,D,J)
Xla Wt + gdf6 MO (Fig.4.F,H,I,J)
Xla Wt + gdf6 MO (Fig.5.A-D, F)
Xla Wt + gdf6 MO (Fig.5.E,F)
Xla Wt + gdf6 MO

	Figure 1. Reduced eye size following GDF6 depletion. (A) In vitro translation of GDF6 mRNA is blocked by GDF6 MOrpholino (GDF6 MO) but is not affected by the standard control MOrpholino (STD MO). (B) Dorsal view of stage 41 tadpole injected with 10 ng GDF6 MO on the left side. (C) Lateral view of tadpoles showing (top to bottom) an unaffected tadpole; GDF6 MO injected sides with an eye 84% of normal contra lateral size and 66% of normal contra lateral size. (D) Graphical representation of the percent of embryos injected with GDF6 MO with the small eye phenotype at stage 41 compared with those injected with STD MO. (E) A severely ventralized embryo injected with 250 pg GDF6 mRNA at stage 41. The percent of ventralized embryos is shown. (F) An example of a partially rescued embryo injected with 250 pg GDF6 mRNA + 20 ng GDF6 MO. The percent of similarly ventralized embryos is shown. (G) A completely rescued embryo injected with 250 pg GDF6 mRNA + 20 ng GDF6 MO. (H) The untreated side of a stage 24 embryo immunostained with anti-phosphorylated-Smad1/5/8 showing staining within the retina and along the neural tube (arrow). Full embryo is shown in the inset. (I) The GDF6 MO (20 ng) injected side of the same embryo showing a loss of phosphorylated-Smad1/5/8 in the retina and neural tube. (J) Frontal view of the same stage 24 embryo showing the reduction in the intensity of the phosphorylated-Smad1/5/8 stain on the injected side (i). (K) Endogenous Smad1/5/8 phosphorylation in St.11.5–12.5 embryonic extracts, lane 2. No Smad phosphorylation is detected in 64 cell embryos lane 1.
	Figure 2. Loss of retinal differentiation and laminar structure in GDF6 depleted embryos. Histology of stage 41 embryos with small eyes following GDF6 MO injection (20 ng) compared with normal stage matched controls. DAPI staining of small eye (B, D, F, and H) compared with normal eye (A, C, E, and G) showing small eyes have a lack of laminar structure and appear disorganized. (A, B) Photoreceptors (p) are not stained in B compared with XAP-1 staining in A. (B) Cell bodies are visibly extending outward (white arrow) but do not stain for XAP-1. Red staining next to the lens is non-specific staining also detected in a proportion of negative controls. (C, D) 40.2D6 detects ganglion (g) and amacrine (a) cells within the normal retina, but these cells are not detected in the small eye. Photoreceptors are visible due to autofluorescence at increased exposure. (E, F) Small disorganized eyes show a loss of immunostaining for the cytoplasmic domain of NCAM (n). (G, H) Mitotic cells (m) detected using anti-phosphorylated-histoneH3 are few and found mainly in the ciliary marginal zone in normal stage 41 embryos. The small eye shows a few mitotic cells near the RPE layer.
	Figure 3. GDF6 knock down causes a loss of Pax6 expression as detected by in situ hybridization. Representative stage 20 embryos injected with 50 ng standard MO (A, D), 20 ng GDF6 MO (B, E), and 50 ng GDF6 MO (C, F). The injected sides are labelled i. Dorsal views show a loss of Pax6 stain within the two rhombomere bands in the hindbrain in the 20 ng GDF6 MO injected embryos (B), and an additional more severe loss of dorsal neural tube staining in the 50 ng GDF6 MO injected embryos (C), compared to the uninjected side (red arrows indicate rhombomeres) and standard MO injected embryos (A). Frontal views show a laterally reduced size of the Pax6 domain (E and F, injected side), compared to Pax6 staining in uninjected side (definition between forebrain and retinal stain indicated with white arrow) and standard MO injected embryo (D). (G, H) Dorsal and lateral views of stage 27 embryos injected with 25 ng of GDF6 MO show a reduced size of the Pax6 domain within the retina and a complete loss of stain within brain on the injected side. (I) Graph showing the percent stage 20 embryos injected at 20 ng and 50 ng of GDF6 MO and Standard MO showing a disruption of normal Pax6 stain.
	Figure 4. GDF6 knockdown disrupts neural differentiation. At neurulation stages, immunostaining for neural cell adhesion molecule (NCAM) is lost or reduced in intensity in the GDF6 MO injected side: A(i), C(i), D, F(i), H(i), I. (A) Stage 24 embryo injected with 50 ng GDF6 MO showing complete loss of NCAM stain along the neural tube on the injected side. Some patchy retina stain remains. This embryo is also curved and appears to be reduced in size on the injected side. (B) Normal NCAM stain in an embryo injected with 50 ng standard MO. (C) Stage 24 embryos injected with 20 ng GDF6 MO with NCAM stain lost along the posterior neural tube (top embryo, arrow marks posterior end of NCAM stain), or along the entire neural tube (bottom embryo). (D, E) Injected (D) and uninjected side (E) of bottom embryo in (C) showing patchy loss of NCAM stain in the retina of the injected side. (F) Dorsal view of stage 27 embryo injected with 50 ng GDF6 MO. The injected side (i) shows a loss of NCAM stain both along the neural tube and within the head and retina. In the head and retina small patches of intense NCAM staining remain. (G) Normal NCAM staining in a stage 27 embryo injected with 50 ng standard MO. (H, I) Full view and close up of a stage 27 embryo injected with 20 ng GDF6 MO. Neural tube NCAM staining is less intense on the injected side (top half of embryo). (J) Percent embryos with NCAM reduction on the injected side following GDF6 MO injection.
	Figure 5. Increased cell death during neurogenesis in GDF6 depleted embryos. (A) Stage 20 embryo injected with 20 ng GDF6 MO shows a patch of TUNEL at the anterior region of the injected side (i). (B) Stage 22 embryo injected with 20 ng GDF6 MO showing TUNEL positive cells near the midline at the anterior region of the injected side (i). (C) Stage 22 embryo injected with 50 ng GDF6 MO showing more extensive TUNEL staining which extends along the length of the injected side (i). There is an obvious reduction in physical size on the injected side. (D) Stage 27 embryo injected with 50 ng GDF6 MO showing dark concentrated TUNEL staining in the brain and retina on the injected side (i). This embryo is also curled towards the injected side. (E) Graphical representation of the percent embryos with increased TUNEL staining on the injected side at stage 20–24 and stage 27. (F, G) The GDF6 MO (25 ng) injected side (F) and uninjected side (G) of a stage 27 embryo, showing heavy TUNEL staining in the retina and brain.

Biehs, The Drosophila short gastrulation gene prevents Dpp from autoactivating and suppressing neurogenesis in the neuroectoderm. 1996, Pubmed, Xenbase

Biehs, The Drosophila short gastrulation gene prevents Dpp from autoactivating and suppressing neurogenesis in the neuroectoderm. 1996, Pubmed , Xenbase
Buskirk, Antibodies to a neural cell adhesion molecule disrupt histogenesis in cultured chick retinae. 1980, Pubmed
Chang, Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. 1999, Pubmed , Xenbase
Chow, Pax6 induces ectopic eyes in a vertebrate. 1999, Pubmed , Xenbase
Délot, The BMP-related protein radar: a maintenance factor for dorsal neuroectoderm cells? 1999, Pubmed
Díaz, In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. 2000, Pubmed
Dudley, Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. 1997, Pubmed
Dunn, Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. 1997, Pubmed , Xenbase
Grindley, The role of Pax-6 in eye and nasal development. 1995, Pubmed
Harland, In situ hybridization: an improved whole-mount method for Xenopus embryos. 1991, Pubmed , Xenbase
Hemmati-Brivanlou, Ventral mesodermal patterning in Xenopus embryos: expression patterns and activities of BMP-2 and BMP-4. 1995, Pubmed , Xenbase
Hensey, Programmed cell death during Xenopus development: a spatio-temporal analysis. 1998, Pubmed , Xenbase
Hensey, Developmental regulation of induced and programmed cell death in Xenopus embryos. 1999, Pubmed , Xenbase
Hirsch, Xenopus Pax-6 and retinal development. 1997, Pubmed , Xenbase
Jena, BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. 1997, Pubmed
Kao, The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. 1988, Pubmed , Xenbase
Kerrison, Bone morphogenetic proteins promote neurite outgrowth in retinal ganglion cells. 2005, Pubmed
Kurata, Visualization of endogenous BMP signaling during Xenopus development. 2001, Pubmed , Xenbase
Lee, Neuronal patterning by BMPs: a requirement for GDF7 in the generation of a discrete class of commissural interneurons in the mouse spinal cord. 1998, Pubmed
Li, A single morphogenetic field gives rise to two retina primordia under the influence of the prechordal plate. 1997, Pubmed , Xenbase
Li, Neuronal differentiation of precursors in the neocortical ventricular zone is triggered by BMP. 1998, Pubmed
Liu, BMP receptor 1b is required for axon guidance and cell survival in the developing retina. 2003, Pubmed
Liu, Bone morphogenetic protein signalling and vertebrate nervous system development. 2005, Pubmed
Luo, BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. 1995, Pubmed
Marquardt, Pax6 is required for the multipotent state of retinal progenitor cells. 2001, Pubmed
Mazerbourg, Identification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analyses. 2005, Pubmed
Meech, A binding site for homeodomain and Pax proteins is necessary for L1 cell adhesion molecule gene expression by Pax-6 and bone morphogenetic proteins. 1999, Pubmed
Mehler, Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. 2000, Pubmed
Murali, Distinct developmental programs require different levels of Bmp signaling during mouse retinal development. 2005, Pubmed
Neiiendam, An NCAM-derived FGF-receptor agonist, the FGL-peptide, induces neurite outgrowth and neuronal survival in primary rat neurons. 2004, Pubmed
Panchision, Sequential actions of BMP receptors control neural precursor cell production and fate. 2001, Pubmed
Perides, Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-beta superfamily. Selective effects of the bone morphogenetic proteins. 1994, Pubmed
Piccolo, Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. 1996, Pubmed , Xenbase
Quiring, Homology of the eyeless gene of Drosophila to the Small eye gene in mice and Aniridia in humans. 1994, Pubmed
Rissi, Zebrafish Radar: a new member of the TGF-beta superfamily defines dorsal regions of the neural plate and the embryonic retina. 1995, Pubmed
Sakuta, Ventroptin: a BMP-4 antagonist expressed in a double-gradient pattern in the retina. 2001, Pubmed , Xenbase
Sasagawa, Axes establishment during eye morphogenesis in Xenopus by coordinate and antagonistic actions of BMP4, Shh, and RA. 2002, Pubmed , Xenbase
Shou, Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage. 2000, Pubmed
Storm, Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. 1994, Pubmed
Storm, GDF5 coordinates bone and joint formation during digit development. 1999, Pubmed , Xenbase
Storm, Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. 1996, Pubmed
Strickler, Early and late changes in Pax6 expression accompany eye degeneration during cavefish development. 2001, Pubmed
Swanson, Disruption of cerebellar granule cell development in the Pax6 mutant, Sey mouse. 2005, Pubmed
Takahashi, CBF1 controls the retinotectal topographical map along the anteroposterior axis through multiple mechanisms. 2003, Pubmed
Timmer, BMP signaling patterns the dorsal and intermediate neural tube via regulation of homeobox and helix-loop-helix transcription factors. 2002, Pubmed
Trousse, Bmp4 mediates apoptotic cell death in the developing chick eye. 2001, Pubmed
Wang, A novel Xenopus homologue of bone morphogenetic protein-7 (BMP-7). 1997, Pubmed , Xenbase
Wawersik, BMP7 acts in murine lens placode development. 1999, Pubmed
Wohabrebbi, Downregulation of a unique photoreceptor protein correlates with improper outer segment assembly. 2002, Pubmed , Xenbase
Wolfman, Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. 1997, Pubmed
Yamamoto, Hedgehog signalling controls eye degeneration in blind cavefish. 2004, Pubmed
Yeo, A role for programmed cell death during early neurogenesis in xenopus. 2003, Pubmed , Xenbase
Yeo, Early neural cell death: dying to become neurons. 2004, Pubmed
Zhang, Temporal and spatial effects of Sonic hedgehog signaling in chick eye morphogenesis. 2001, Pubmed
Zimmerman, The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. 1996, Pubmed , Xenbase